Vakifbank to Include Deposit Automation Functionality

Diebold, a leading provider of self-service and safety solutions, has made an automated teller machine (ATM) and software agreement with Vakifbank, for promoting the bank’s ATM network. The installation of the ATM terminals will commence after completing the incorporation of the Diebold Agilis software certification into the existing software platform of the bank.

As per this contract, Diebold will offer 575 image-enabled Opteva ATMs provided with enhanced note acceptor (ENA) and coin dispensing machines. These ATM terminals can also be used for cash deposits and bill payments. The terminus of Vakifbank will be handled by the adaptive Agilis application. The automated depositing feature in the ATM channels will help the bank in enhancing currency management, reducing risk and streamlining the transaction process at its ATM terminals.

Danilo Rivalta, VP and GM, Diebold EMEA Southern and Central region, has stated that their partnership with Vakifbank served as a landmark for their company’s presence in Turkey which is one of their significant markets in EMEA. He expressed that their company is honored to be selected by Vakifbank for improving the infrastructure of its ATM network.

Diebold has developed ENA for augmenting deposit automation, by utilizing its technology proficiency and experience in the automation industry.  With the help of ENA, a stack of maximum 50 mixed denomination currency can be deposited without an envelope. It offers quick and accurate validation and verification of the deposited currency. The ENA module also uses Diebold’s dual slot solution for providing two stages of input during the operation, ensuring continual inflow of currency and customers’ satisfaction. The ENA improves the adaptability of the ATM terminals and it can be either included as a standard feature or as an onsite update.

Retail Banking Research (RBR) has announced that between 2007 and 2009, the number of ATM terminals featuring the automated deposition has augmented up to 30%.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.